Step Pharma announces the appointment of Neil Gallagher as Non-Executive Director

Step Pharma appoints Neil J. Gallagher, MD, PhD as Non-Executive Director to strengthen its board as it advances dencatistat, a first-in-class CTPS1 inhibitor, across three clinical programmes for essential thrombocythaemia, lymphoma, and solid tumours. Gallagher brings over 25 years of clinical development experience from senior roles at major pharmaceutical companies including Amgen, AstraZeneca, Novartis, and AbbVie.